Xiangyu Medical Co (SHSE:688626) Gross Margin %: 67.02% (As of Jun. 2026) — Near Median

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

SHSE:688626 Xiangyu Medical Co Ltd SHSE:688626
91 GF Score
Price ¥39.72
GF Value ¥46.28
Valuation Modestly Undervalued
! 4 Warning Signs
View Full Analysis

What is Xiangyu Medical Co Gross Margin %?

Xiangyu Medical Co SHSE:688626 -0.90% 91 Gross Margin % is 67.02% as of Jun. 2026, which is 1% above its 10-year median of 66.63. GuruFocus rates SHSE:688626 with a GF Score™ of 91/100 and a GF Value™ of ¥46.28 (Modestly Undervalued). The stock has 4 warning signs investors should review. Among 804 Medical Devices & Instruments companies, Xiangyu Medical Co ranks better than 73.38% on this metric.

Gross Margin % is calculated as gross profit divided by its revenue. Xiangyu Medical Co's Gross Profit for the three months ended in Jun. 2026 was ¥120.7 Mil. Xiangyu Medical Co's Revenue for the three months ended in Jun. 2026 was ¥180.1 Mil. Therefore, Xiangyu Medical Co's Gross Margin % for the quarter that ended in Jun. 2026 was 67.02%.


The historical rank and industry rank for Xiangyu Medical Co's Gross Margin % or its related term are showing as below:

SHSE:688626' s Gross Margin % Range Over the Past 10 Years
Min: 59.59   Med: 66.63   Max: 68.62
Current: 66.52


During the past 9 years, the highest Gross Margin % of Xiangyu Medical Co was 68.62%. The lowest was 59.59%. And the median was 66.63%.

SHSE:688626's Gross Margin % is ranked better than
73.38% of 804 companies
in the Medical Devices & Instruments industry
Industry Median: 52.44 vs SHSE:688626: 66.52

Xiangyu Medical Co had a gross margin of 67.02% for the quarter that ended in Jun. 2026 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Xiangyu Medical Co was -0.20% per year.


Xiangyu Medical Co  (SHSE:688626) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Xiangyu Medical Co had a gross margin of 67.02% for the quarter that ended in Jun. 2026 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Xiangyu Medical Co Gross Margin % Related Terms


Xiangyu Medical Co Gross Margin % Historical Data

* Premium members only.

The historical data trend for Xiangyu Medical Co's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Xiangyu Medical Co Gross Margin % Chart

Xiangyu Medical Co Annual Data
Trend Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Gross Margin %
Get a 7-Day Free Trial Premium Member Only 68.23 66.27 68.62 67.42 66.63

Xiangyu Medical Co Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 70.71 65.75 65.32 68.20 67.02

SHSE:688626 vs ABT, SYK, MDT: Gross Margin % Comparison

For the Medical Devices subindustry, Xiangyu Medical Co's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Xiangyu Medical Co Gross Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Xiangyu Medical Co's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Xiangyu Medical Co's Gross Margin % falls into.


SHSE:688626
91GF Score
Xiangyu Medical Co Ltd SHSE:688626
Gross Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Xiangyu Medical Co Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Xiangyu Medical Co's Gross Margin for the fiscal year that ended in Dec. 2025 is calculated as

Gross Margin % (A: Dec. 2025 )=Gross Profit (A: Dec. 2025 ) / Revenue (A: Dec. 2025 )
=511.5 / 767.747
=(Revenue - Cost of Goods Sold) / Revenue
=(767.747 - 256.205) / 767.747
=66.63 %

Xiangyu Medical Co's Gross Margin for the quarter that ended in Jun. 2026 is calculated as


Gross Margin % (Q: Jun. 2026 )=Gross Profit (Q: Jun. 2026 ) / Revenue (Q: Jun. 2026 )
=120.7 / 180.087
=(Revenue - Cost of Goods Sold) / Revenue
=(180.087 - 59.385) / 180.087
=67.02 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.

Frequently Asked Questions Learn more about Gross Margin % →
What does a Gross Margin % of 67.02% mean?
Xiangyu Medical Co (SHSE:688626) has a Gross Margin % of 67.02% as of Jun. 2026. Gross margin is the ratio of total gross profit to net sales. View historical data on Xiangyu Medical Co and its competitors. This is near median its historical median of 66.63. Over the past decade, Xiangyu Medical Co's Gross Margin % has ranged from 59.59 to 68.62. According to the industry distribution chart, Xiangyu Medical Co ranks #214 out of 804 companies in the Medical Devices & Instruments industry, placing it in the top 26.6%.
Is Xiangyu Medical Co's Gross Margin % too high?
Xiangyu Medical Co's current Gross Margin % of 67.02% is near median its 10-year median of 66.63. Over the past 10 years, this metric has ranged from a low of 59.59 to a high of 68.62. The Medical Devices & Instruments industry median Gross Margin % is 52.44. Xiangyu Medical Co's value of 67.02% is 27.8% above this industry median. Based on the distribution chart, Xiangyu Medical Co ranks #214 out of 804 companies in the Medical Devices & Instruments industry, which is above the industry midpoint. Overall, Xiangyu Medical Co has a GF Score™ of 91/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Xiangyu Medical Co's Gross Margin % compare to ABT and SYK?
According to the Medical Devices & Instruments industry distribution chart, Xiangyu Medical Co ranks #214 out of 804 companies for Gross Margin %. This puts Xiangyu Medical Co in the upper half of its industry. The industry median Gross Margin % is 52.44. Xiangyu Medical Co's value of 67.02% is 27.8% above this benchmark. Historically, Xiangyu Medical Co's own Gross Margin % has ranged from 59.59 to 68.62 over the past decade. While the company's 10-year median is 66.63 vs. the industry median of 52.44, Xiangyu Medical Co has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Gross Margin % for a Medical Devices & Instruments company?
The median Gross Margin % among Medical Devices & Instruments companies is 52.44, based on 804 companies in the industry. Companies in the top quartile (top 25%) have a Gross Margin % significantly above this median, while those in the bottom quartile fall well below. However, Gross Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Xiangyu Medical Co's current Gross Margin % of 67.02% is 27.8% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Gross Margin % mean?
A high Gross Margin % can signal that a stock is expensive relative to its fundamentals. Gross margin is the ratio of total gross profit to net sales. View historical data on Xiangyu Medical Co and its competitors. For the Medical Devices & Instruments industry, the median Gross Margin % is 52.44 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Xiangyu Medical Co's current Gross Margin % is 67.02%, which is near median its own 10-year median of 66.63. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Xiangyu Medical Co stock overvalued right now?
Based on GuruFocus' analysis, Xiangyu Medical Co (SHSE:688626) is currently considered Modestly Undervalued. The stock's GF Value™ is ¥46.28, compared to a current price of ¥39.72 — trading 14.2% below its estimated fair value. The current Gross Margin % is 67.02%, which is near median its 10-year median of 66.63 and 27.8% above the Medical Devices & Instruments industry median of 52.44. Xiangyu Medical Co's overall GF Score™ is 91/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Gross Margin % calculated?
Gross Margin % is calculated from a company's financial statements. For Xiangyu Medical Co (SHSE:688626), the current Gross Margin % is 67.02% as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Xiangyu Medical Co (SHSE:688626) Overvalued in 2026?

Based on GuruFocus' analysis, Xiangyu Medical Co stock appears to be undervalued. The current stock price of ¥39.72 is trading 14.2% below its estimated GF Value™ of ¥46.28. GuruFocus considers Xiangyu Medical Co to be Modestly Undervalued.

Key valuation signals for SHSE:688626:

  • Gross Margin %: 67.02% (near median its 10-year median of 66.63)
  • GF Value™: ¥46.28 vs. price of ¥39.72 (14.2% below fair value)
  • GF Score™: 91/100 with 4 warning signs
  • Industry Position: 27.8% above the Medical Devices & Instruments median (#214 of 804)

No single metric tells the full story. See the SHSE:688626 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Xiangyu Medical Co Business Description

Address Middle Section of Dixu Avenue, Neihuang County, Henan Province, Anyang, CHN, 456300
Xiangyu Medical Co Ltd is engaged in independent research and development, production and sales of intelligent rehabilitation equipment in the fields of pain rehabilitation, neurorehabilitation, orthopedics rehabilitation, postpartum rehabilitation, and medical care integration. The company's products are divided into three categories: rehabilitation assessment, rehabilitation training, and rehabilitation physiotherapy.
91GF Score

Get the complete analysis for SHSE:688626

Gross Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

¥39.72
Price
¥46.28
GF Value